Key result
Alcohol septal ablation acutely improves LAD microvascular function in oHCM, raising CFR by ~28%.
Why the study?
In obstructive hypertrophic cardiomyopathy, whether coronary microvascular dysfunction is diffuse or regionally localised, and how septal reduction therapy acutely affects it, remained unclear.
Does alcohol septal ablation acutely improve invasive indices of coronary microvascular dysfunction in the LAD and LCx territories in symptomatic patients with obstructive hypertrophic cardiomyopathy?
Observational (n=20)
Does alcohol septal ablation acutely improve invasive indices of coronary microvascular dysfunction in the LAD and LCx territories in symptomatic patients with obstructive hypertrophic cardiomyopathy?
Answers are grounded in this paper and cite their sources.
In symptomatic obstructive hypertrophic cardiomyopathy, coronary microvascular dysfunction is predominantly localized to the LAD territory and is acutely improved immediately following alcohol septal ablation alongside LVOT gradient relief.
Background Coronary microvascular dysfunction (CMD) is increasingly recognised as an important pathophysiological substrate for myocardial ischaemia and adverse outcomes in obstructive hypertrophic cardiomyopathy (oHCM). However, whether CMD is diffuse or regionally localised, and how septal reduction therapy acutely affects CMD, remains unclear. Purpose To evaluate the regional distribution of CMD in the left anterior descending artery (LAD) and left circumflex artery (LCx) territories in symptomatic oHCM and to assess acute changes in invasive CMD indices immediately after alcohol septal ablation (ASA). Methods Consecutive symptomatic patients with oHCM undergoing ASA were enrolled (n=20; median age 72 [61–76] years; 30% male; New York Heart Association class II–III). Coronary microvascular function was invasively assessed using a pressure/temperature guidewire to measure coronary flow reserve (CFR) and index of microcirculatory resistance (IMR) in both the LAD and LCx territories before and immediately after ASA (Figure A). CMD was defined as CFR <2.0 and/or IMR >25. Results ASA significantly reduced the left ventricular outflow tract pressure gradient from 53 [13–69] mmHg to 6 [3–8] mmHg (p<0.001). At baseline, CMD was observed in the LAD, with reduced CFR (1.8 [1.3–2.1]) and elevated IMR (26 [25–39]). Immediately after ASA, LAD microvascular function improved, with increased CFR (2.3 [2.0–2.9], p=0.004) and decreased IMR (17 [13–22], p=0.002) (Figure B). In contrast, LCx indices were preserved at baseline (CFR 2.1 [1.6–3.1], IMR 14 [11–25]) and showed no significant change after ASA (Figure B). No major procedure-related complications occurred. Conclusions In symptomatic oHCM, CMD predominantly localises to the LAD territory, whereas the LCx territory exhibits preserved microvascular function. ASA acutely improves LAD-associated CMD in parallel with haemodynamic relief, suggesting potential benefits beyond gradient reduction. Regional invasive CMD assessment may provide mechanistic insights into oHCM and serve as a useful tool for evaluating the immediate physiological impact of ASA.
No takes yet. Share an insight, caveat, or question.
Terauchi et al. (2026) conducted an observational in Symptomatic obstructive hypertrophic cardiomyopathy (oHCM) (n=20). Alcohol septal ablation (ASA) vs. Pre-ASA baseline (and LAD vs LCx territory comparison) was evaluated on Invasive coronary microvascular function indices: coronary flow reserve (CFR) and index of microcirculatory resistance (IMR) in the LAD and LCx territories (p=0.004). Alcohol septal ablation acutely improved LAD coronary microvascular function in oHCM, increasing CFR from 1.8 to 2.3 and decreasing IMR from 26 to 17.
Synapse has enriched 10 related papers. Consider them for comparative context: